Loading...
The markedly improved survival for HIV-infected patients receiving antiretroviral therapy is resulting in an aging population at risk for the major diseases of the elderly, including cancer. Given that even well-managed HIV infection is associated with persistent immune abnormalities, there is interest in determining treatment outcomes among HIV-infected persons with cancer.
To that end, investigators analyzed data from a U.S. Medicare database on 307,980 HIV-uninfected persons and 288 HIV-infected persons (ages, ≥65 years old) diagnosed with nonadvanced colorectal, lung, prostate, or breast cancer between 1996 and 2012. Patients had received standard cancer treatment during the first year after cancer diagnosis. The follow-up period started…